Feedback to Pharmac on consideration of erenumab (Aimovig)
Migraine Foundation Aotearoa New Zealand has submitted feedback to Pharmac and PTAC following its consideration of erenumab (Aimovig) for prophylactic treatment of migraine. Pharmac is the agency in Aotearoa New Zealand that is responsible for deciding what medicines to fund. Pharmac operates from a fixed budget, which is set by the Government. To help in […]
